Product Information
MICONAZOLE-ZINC-PETRO 0.25-15% is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $9.1207 per GM under NDC 00378822250. Its NADAC has been published 55 times since Sep 17, 2025.
FDA first approved this application on Feb 16, 2006.
Strength
2.5; 813.5; 150 mg/g; mg/g; mg/g
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378822250
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
1/21/2026
Active Ingredients
MICONAZOLE NITRATE; PETROLATUM; ZINC OXIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021026FDA Approved
2/16/2006
On Market Since
11/6/2018
Pharmacological Classes
Price Statistics
The NADAC for MICONAZOLE-ZINC-PETRO 0.25-15% has been published 55 times since Sep 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.1207 per GM |
|---|---|
| All-time high | $9.1207 (Sep 30, 2026) |
| All-time low | $9.1003 (Sep 17, 2025) |
| 52-week high | $9.1207 |
| 52-week low | $9.1003 |
| Median price | $9.1207 |
| Average price | $9.1176 |
| Largest weekly change | +0.1% (Oct 22, 2025) |
| Weeks tracked | 55 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the miconazole nitrate, zinc oxide, white petrolatum market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
miconazole nitrate, zinc oxide, white petrolatum market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MICONAZOLE-ZINC-PETRO 0.25-15%?
The current National Average Drug Acquisition Cost (NADAC) for MICONAZOLE-ZINC-PETRO 0.25-15%, manufactured by Mylan Pharmaceuticals Inc., is $9.1207 per GM (NDC 00378822250), effective Sep 30, 2026.
How has the price of MICONAZOLE-ZINC-PETRO 0.25-15% changed over time?
Over the history we have for it, the NADAC for MICONAZOLE-ZINC-PETRO 0.25-15% has held within roughly two percent of its current level. It has been tracked across 55 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for MICONAZOLE-ZINC-PETRO 0.25-15%?
Since Sep 17, 2025, the NADAC for MICONAZOLE-ZINC-PETRO 0.25-15% has ranged from a low of $9.1003 (Sep 17, 2025) to a high of $9.1207 (Sep 30, 2026), with a median of $9.1207 per GM.
Are there cheaper alternatives to MICONAZOLE-ZINC-PETRO 0.25-15%?
No other NADAC-published product currently shares the active ingredient and strength of MICONAZOLE-ZINC-PETRO 0.25-15% in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MICONAZOLE-ZINC-PETRO 0.25-15%?
MICONAZOLE-ZINC-PETRO 0.25-15% (NDC 00378822250) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.